Company: OXBRW
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-023960
Chunk: 37

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 37
---
 we undertake (if any),
as we are able to deploy new capital to collateralize new reinsurance treaties and consequently, earn additional premium revenue. In
addition, our results of operations may be seasonal in that hurricanes and other tropical storms typically occur during the period from
June 1 through November 30. Further, our results of operations may be subject to significant variations due to factors affecting the
property and casualty insurance industry in general, which include competition, legislation, regulation, general economic conditions,
judicial trends, and fluctuations in interest rates and other changes in the investment environment.

Because
we employ an opportunistic underwriting and investment philosophy, period-to-period comparisons of our underwriting results may not be
meaningful. In addition, our historical investment results may not necessarily be indicative of future performance. Due to the nature
of our reinsurance and investment strategies, our operating results will likely fluctuate from period to period.

Compared
to most of our competitors, we are small and have low overhead expenses. We believe that our expense efficiency, agility and existing
relationships support our competitive position and allows us to profitably participate in lines of business that fit within our strategy.
Over time we expect our expense advantage to erode as the industry acts to reduce frictional costs.

Recent
Developments

Formation
of SurancePlus

SurancePlus,
an indirectly owned subsidiary of the Company, was incorporated as a British Virgin Islands Business Company on December 19, 2022 for
the purpose of tokenizing reinsurance contracts underwritten by its affiliated licensed reinsurer, Oxbridge Re NS.

On
March 27, 2023, we, through SurancePlus, issued a press release announcing the commencement of an offering by SurancePlus of up to $5.0
million of DeltaCat Re Tokens with a purchase price of $10.00 per DeltaCat Re Token and representing one share of Series DeltaCat Re
Preferred Shares per DeltaCat Re Token (the “Private Placement”).

On
June 27, 2023, SurancePlus completed the Private Placement. The aggregate amount raised in the Private Placement was $2,447,760 for the
issuance of 244,776 DeltaCat Re Tokens, of which approximately $1,280,000 was received from third-party investors and approximately $1,167,000
was received from Oxbridge Re Holdings Limited.

On
September 11, 2023, the DeltaCat Re tokens were reclassified as tokenized interests carrying